Cipla, INE059A01026

Macquarie raises target for Cipla stock to INR 1,730

Published on 10/13/2026 at 09:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-quarter net income fell 39.00 percent to INR 7.89 billion. Cipla stock faces results on October 27, 2026 amid margin pressure.

  • Macquarie raised its Cipla target from INR 1,675 to INR 1,730 on October 7, 2026.
  • First-quarter 2027 net income fell 39.00 percent year over year to INR 7.89 billion.
  • Cipla reported first-quarter revenue of INR 71.19 billion, up 3.50 percent year over year.
  • The board is scheduled to consider second-quarter and first-half results on October 27, 2026.
Cipla, INE059A01026, Illustration mit AI erstellt.
Cipla, INE059A01026, Illustration mit AI erstellt.

Cipla (INE059A01026) entered the October 13, 2026 session with Macquarie's target at INR 1,730, up from INR 1,675 on October 7, 2026. Univest reported the Buy rating and target change. The next test is operational: first-quarter 2027 net income fell 39.00 percent year over year to INR 7.89 billion.

Three dates explain the shift

On June 25, 2026, Cipla shareholders approved an annual dividend of INR 13.00 per share, according to the NSE India company page. On July 23, 2026, first-quarter 2027 results showed revenue of INR 70.77 billion and net income of INR 7.89 billion, according to Simply Wall St. The latest dated event came on October 7, 2026, when Macquarie lifted its target to INR 1,730 from INR 1,675, as Univest reported.

What must margins recover to?

The earnings mix explains why the target increase faces a numerical counterweight. First-quarter revenue rose 3.50 percent year over year to INR 70.77 billion, while earnings per share fell to INR 9.77 from INR 16.07 and net income declined 39.00 percent, according to StockFin. The same report puts the operating margin at 12.50 percent in June 2026, down from 21.10 percent in September 2025, while the outlook cited by Univest was 18.50 percent to 20.00 percent for the fiscal year.

Results date sets the next checkpoint

Cipla's board is scheduled to meet on October 27, 2026, to consider unaudited results for the quarter and half year ended September 30, 2026, according to The Economic Times. The trading window is scheduled to remain closed from October 1 through October 29, 2026, according to the same company announcement. The key figure will be the operating margin, because the gap between 12.50 percent in the latest quarter and the 18.50 percent lower guidance threshold defines the recovery hurdle.

Market value and listing

Cipla's market capitalization was INR 1.1 trillion on October 13, 2026, while the NSE-listed stock's 52-week range was INR 1,165.70 to INR 1,673.00, according to the NSE India quote page. For investors, the numerical debate is therefore clear: Macquarie's INR 1,730 target depends on earnings normalization, while the next reported margin will show whether that thesis is gaining support.

Dates and market data

  • Company: Cipla Limited
  • ISIN: INE059A01026
  • Ticker: CIPLA
  • Primary exchange: National Stock Exchange of India
  • Market capitalization: INR 1.1 trillion (as of October 13, 2026)
  • 52-week range: INR 1,165.70-1,673.00
  • Sector / Industry: Healthcare / Pharmaceuticals
  • Index membership: Nifty 50
  • Next earnings date: October 27, 2026

Market context: Market report BSE Sensex.

More news and analyses on Cipla stock

Disclaimer...

en | INE059A01026 | CIPLA | boerse | 70311215 | bgmi